Literature DB >> 3813534

Glial-derived neurite-promoting factor is a slow-binding inhibitor of trypsin, thrombin, and urokinase.

S R Stone, H Nick, J Hofsteenge, D Monard.   

Abstract

Glial-derived neurite-promoting factor was found to be a slow-binding inhibitor of trypsin, urokinase, and thrombin. The kinetic mechanism of the inhibition differs among the three proteases. With trypsin and urokinase, an initial protease-factor complex formed which isomerized to a tighter complex. For thrombin, however, no initial complex was kinetically observed. The dissociation constants of the equilibrium complexes of the factor with trypsin, urokinase, and thrombin were 17, 280, and 18 pM, respectively, and the apparent second-order rate constants for the interaction of the factor with these enzymes were, respectively, 4.7 X 10(6), 1.2 X 10(5), and 2.1 X 10(6) M-1S-1. Heparin increased the rate at which the factor reacted with thrombin by over 40-fold to 8.9 X 10(7) M-1S-1 and decreased the dissociation constant of the complex by over 80-fold to 0.3 pM. The values obtained for the apparent second-order rate constants when compared with the kinetics of neurite induction by the factor indicate that the neurite-promoting activity of the factor is not due to the inhibition of urokinase but could be due to the inhibition of an enzyme with a specificity similar to that of thrombin or trypsin. Comparison of the values of the apparent second-order rate constants obtained for the factor with those obtained for protease nexin suggests that these two molecules are very similar in their inhibitory properties.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3813534     DOI: 10.1016/0003-9861(87)90028-2

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  18 in total

1.  Male fertility defects in mice lacking the serine protease inhibitor protease nexin-1.

Authors:  V Murer; J F Spetz; U Hengst; L M Altrogge; A de Agostini; D Monard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

2.  Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice.

Authors:  R Madani; S Hulo; N Toni; H Madani; T Steimer; D Muller; J D Vassalli
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

3.  Interaction of activated protein C with serpins.

Authors:  J M Hermans; S R Stone
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

4.  Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation.

Authors:  A Lüthi; H Van der Putten; F M Botteri; I M Mansuy; M Meins; U Frey; G Sansig; C Portet; M Schmutz; M Schröder; C Nitsch; J P Laurent; D Monard
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

5.  Expression pattern of human SERPINE2 in a variety of human tumors.

Authors:  Ying Yang; Xiangke Xin; Xing Fu; Danmei Xu
Journal:  Oncol Lett       Date:  2018-01-18       Impact factor: 2.967

6.  The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin.

Authors:  H S Suidan; K J Clemetson; M Brown-Luedi; S P Niclou; J M Clemetson; J Tschopp; D Monard
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

7.  Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma.

Authors:  Chad M McKee; Danmei Xu; Yunhong Cao; Sheheryar Kabraji; Danny Allen; Veerle Kersemans; John Beech; Sean Smart; Freddie Hamdy; Adrian Ishkanian; Jenna Sykes; Melania Pintile; Michael Milosevic; Theodorus van der Kwast; Gaetano Zafarana; Varune Rohan Ramnarine; Igor Jurisica; Chad Mallof; Wan Lam; Robert G Bristow; Ruth J Muschel
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

8.  Effect of heparin on the glia-derived-nexin-thrombin interaction.

Authors:  A Wallace; G Rovelli; J Hofsteenge; S R Stone
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

9.  Structural differences between active forms of plasminogen activator inhibitor type 1 revealed by conformationally sensitive ligands.

Authors:  Shih-Hon Li; Natalia V Gorlatova; Daniel A Lawrence; Bradford S Schwartz
Journal:  J Biol Chem       Date:  2008-04-24       Impact factor: 5.157

10.  Immunohistochemical demonstration of bikunin, a light chain of inter-alpha-trypsin inhibitor, in human brain tumors.

Authors:  E Yoshida; M Maruyama; M Sugiki; H Mihara
Journal:  Inflammation       Date:  1994-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.